Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. VG Life Sciences Inc. (VGLS) Message Board

Latest VG Life Sciences Inc. (VGLS) Headlines VG

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 17
Posted On: 03/12/2014 12:49:26 AM
Avatar
Posted By: Stock_Tracker
Latest VG Life Sciences Inc. (VGLS) Headlines

VG Life Sciences, Inc. Increases Authorized Shares
GlobeNewswire - Thu Jan 02, 11:15PM CST
VG Life Sciences, Inc., (OTC Pink: VGLS) a biotechnology company. Pursuant to a vote of the holders having a majority of the votes of the Company on December 31, 2013, the number of authorized shares of Common Stock of the Company has been increased to 150,000,000.

VG Life Sciences, Inc. December 2013 Shareholder Letter
GlobeNewswire - Wed Dec 18, 12:12AM CST
VG Life Sciences, Inc., VGLS (formerly known as Viral Genetics) is a Santa Barbara, California-based biotechnology company focused on discovering and developing drug therapies for cancer, infectious disease, and inflammatory, autoimmune disorders. VGLS controls over 50 US and international patents and pending patents protecting its exclusive biotech platform technologies. Today the Company posted on its website (www.vglifesciences.com) the following December 2013 Shareholder Letter:

VG Life Sciences, Inc. Update on Phase I Cancer Study
PR Newswire - Fri Dec 13, 5:00AM CST
VG Life Sciences, (OTC Pink: VGLS) a biotechnology company, announces today an update to its Physician-IND Phase I Study to test tolerability and toxicity of its patented technology in patients with advanced stage solid tumors.

VG Life Sciences, Inc. Announces the Initiation of IND-Enabling Animal Safety Studies
PR Newswire - Mon Nov 04, 5:00AM CST
VG Life Sciences, Inc. is a publicly traded (VGLS) biotechnology company focused on developing treatments for patients suffering autoimmune and infectious diseases.

US Patent Office Issues Patent for VG Life Sciences' Peptide for HIV Treatment
PR Newswire - Thu Oct 31, 5:00AM CDT
VG Life Sciences, Inc. is a publicly traded (VGLS) biotechnology company focused on developing treatments for patients suffering autoimmune and infectious diseases.

VG Life Sciences Starts Prior Year Audit to Increase Financial Accountability
PR Newswire - Wed Oct 16, 5:00AM CDT
VG Life Sciences, Inc. (VGLS) is a publicly traded biotechnology company focused on developing treatments for patients suffering autoimmune and infectious diseases.

VG Energy Chief Scientist Awarded $200,000 AgriLife Grant to Study Lipid Secretion
PR Newswire - Thu Aug 08, 6:50PM CDT
VG Energy, an agricultural biotech company and wholly owned subsidiary of publicly traded VG Life Sciences Inc. (VGLS), announces today a $200,000 competitive grant from the Texas A&M AgriLife Research BioEnergy Initiatives Program for testing oil secretion technology.

VG Life Sciences, Inc. Reports on Scientific Advancements: Completion of Third Cohort of Phase I Clinical Trial; Grant from the American Heart Association; UniQuest Reports on LipidMax
PR Newswire - Thu Jul 25, 5:00AM CDT
SANTA BARBARA, Calif., July 25, 2013 /PRNewswire/--- VG Life Sciences, (OTC Pink: VGLS) a biotechnology company, announces today several advancements as it relates to its scientific advancements

VG Life Sciences, Inc. Announces Management Changes
PR Newswire - Thu Jul 18, 7:30AM CDT
VG Life Sciences, (OTC Pink: VGLS) a biotechnology company, announces alterations in its corporate management and management structure.

VG Energy Enters into a Strategic Alliance with DAK Renewable Research for LipidMax Field Trials
PR Newswire - Thu May 23, 10:24AM CDT
VG Energy, an agricultural biotech company, announces today a strategic alliance with DAK Renewable Research to conduct field trials using LipidMax to increase the corn oil yield. VG Energy is a majority owned subsidiary of VG Life Sciences, Inc. (OTC Pink: VGLS).

VG Life Sciences Reports Positive Safety Results from Second Cohort Enrollment in Solid Tumor Clinical Trial
PR Newswire - Thu Apr 04, 7:03AM CDT
VG Life Sciences, Inc. (OTC Pink: VGLS), a biotechnology company focused on leveraging its innovative platform technologies for the discovery and development of drug therapies for cancer, infectious disease, and inflammation, announced today positive results from stage two of its Pre-IND Phase I Study to test tolerability and toxicity in patients with advanced stage solid tumors. The study, which is ongoing in patients with refractory or relapsed solid tumors, examines the safety and efficacy of hydroxychloroquine (HCQ), developed with VGLS' proprietary metabolic disruption technology (MDT), in combination with sorafenib (marketed as Nexavar®), which was co-developed by Bayer AG and Onyx Pharmaceuticals.

VG Life Sciences, Inc. Secures Two-Year Funding Commitment and Administrative Support from MedBridge, LLC
PR Newswire - Fri Mar 22, 8:00AM CDT
VG Life Sciences, Inc. (OTC Pink: VGLS), a biotechnology company focused on leveraging its innovative platform technologies for the discovery and development of drug therapies for cancer, infectious disease, and inflammation, announced today that it has signed a two-year commitment to provide funding toward the operational needs of the company from current investor MedBridge, LLC, a leading provider of development, turnaround, partnership advising and revenue cycle management services for the medical and healthcare industries. During this period, MedBridge will also provide full administrative support for VG Life Sciences, allowing the company to focus on clinical development of its therapeutic pipeline.

VG Life Sciences Subsidiary, VGEnergy, Hires Chief Science Advisor
Business Wire - Thu Feb 28, 7:30AM CST
VG Life Sciences (OTC Pink: VGLS) announces that Martin B. Dickman, Ph.D., has joined its subsidiary VGEnergy, as Chief Science Advisor. In concert with the company's Board of Directors, Dr. Dickman will enhance the scientific rigor of the company's alternative energy core technology platform and expand development of a pipeline of products that enhance the lipid and sugar production in emerging market sectors, such as algal biofuels, and significantly, in more mature and much larger markets, such as corn and sugar cane.

VG Life Sciences Reports Positive Results from First Stage of Ovarian Cancer Clinical Trial Using Sorafenib (Nexavar) Combined with Hydroxychloroquine
Business Wire - Thu Jan 31, 7:30AM CST
--Company Proceeds to Second Set of Patients

VG Life Sciences Expands Ovarian Cancer Trial; Approved to Study Treatment of Breast, Colon, Lung, Liver and Pancreas Cancer
Business Wire - Mon Jan 14, 3:06PM CST
VG Life Sciences (OTC Pink: VGLS), has received approval from the Institutional Review Board of the University of Texas Health Science Center San Antonio to expand the types of cancers being studied in the Company's ongoing physician-initiated Phase 1 clinical trial. The IRB action allows the study to immediately broaden scope to the treatment of all solid tumors, which includes a wide and diverse range of cancer types including breast, colon, lung, liver and pancreas cancer. Effective immediately, principal investigator Dr. Tyler Curiel will begin screening patients with all solid tumors to study the safety of hydroxychloroquine (HCQ) in combination with sorafenib (marketed as Nexevar(TM) by Bayer AG). VG Life Sciences holds the exclusive worldwide license to the body of patents underlying the use of MDT compounds in the treatment of cancers.


(0)
(0)




VG Life Sciences Inc. (VGLS) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us